TABLE 7.
Results of cox model for OS, RFS, Relapse, and NRM
OS | RFS | Relapse | NRM | ||||||
---|---|---|---|---|---|---|---|---|---|
n | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
Acute GVHD* | |||||||||
No acute GVHD | 93 | Reference | Reference | Reference | Reference | ||||
l-llaGVHD& Liver (−) | 79 | 0.87 (0.57–1.33) | 0.517 | 0.89 (0.59–1.36) | 0.599 | 1.67 (0.82–3.41) | 0.161 | 0.60 (0.35–1.04) | 0.068 |
l-llaGVHD& Liver (+) | 14 | 1.12 (0.52–2.40) | 0.778 | 1.09 (0.51–2.34) | 0.819 | 0.45 (0.06–3.50) | 0.444 | 1.37 (0.60–3.14) | 0.459 |
lll-IV aGVHD & Liver (−) | 38 | 1.44 (0.87–2.40) | 0.160 | 1.41 (0.85–2.33) | 0.187 | 0.77 (0.22–2.73) | 0.687 | 1.63 (0.93–2.85) | 0.088 |
lll-IV aGVHD & Liver (+) | 25 | 5.26 (3.15–8.76) | <0.001 | 5.10 (3.07–8.47) | <0.001 | 0.88 (0.11–6.80) | 0.901 | 6.57 (3.82–11.30) | <0.001 |
Contrast lll-IV aGVHD & Liver (+) vs lll-IV aGVHD & Liver (−) | 3.65 (2.00–6.65) | <0.001 | 3.62 (1.99–6.61) | <0.001 | 1.14 (0.12–11.09) | 0.910 | 4.03 (2.14–7.61) | <0.001 | |
Chronic GVHD* | |||||||||
No chronic GVHD | 73 | Reference | Reference | Reference | Reference | ||||
cGVHD & Liver (−) | 83 | 1.17 (0.63–2.18) | 0.620 | 1.39 (0.76–2.57) | 0.288 | 1.03 (0.37–2.84) | 0.954 | 1.67 (0.77–3.63) | 0.192 |
cGVHD & Liver (+) | 93 | 1.50 (0.78–2.88) | 0.225 | 1.71 (0.89–3.27) | 0.108 | 0.70 (0.22–2.26) | 0.551 | 2.56 (1.14–5.73) | 0.022 |
Contrast cGVHD & Liver (+) vs cGVHD & Liver (−) |
1.28 (0.80–2.05) | 0.303 | 1.22 (0.77–1.95) | 0.395 | 0.68 (0.27–1.69) | 0.405 | 1.53 (0.88–2.66) | 0.135 | |
Contrast III-IV aGVHD & Liver (+) and cGVHD & Liver (+) vs III-IV aGVHD & Liver (−) and cGVHD & Liver (−) |
4.67 (2.15–10.13) | <0.001 | 4.43 (2.05–9.60) | <0.001 | 0.77 (0.07–9.16) | 0.839 | 6.16 (2.62–14.49) | <0.001 |